Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
4.420
+0.010 (0.23%)
At close: Dec 5, 2025, 4:00 PM EST
4.450
+0.029 (0.67%)
After-hours: Dec 5, 2025, 5:26 PM EST
Arbutus Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -42.28 | -69.92 | -72.85 | -69.46 | -76.25 | -63.75 | |
| Depreciation & Amortization | 0.69 | 1.38 | 1.4 | 1.43 | 1.75 | 1.98 | |
| Loss (Gain) From Sale of Assets | - | - | -0.02 | - | - | - | |
| Asset Writedown & Restructuring Costs | 2.81 | 0.17 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | -2.85 | -3.14 | -2.2 | -0.05 | 1 | 0.21 | |
| Loss (Gain) on Equity Investments | - | - | - | - | - | 2.55 | |
| Stock-Based Compensation | 7.32 | 8.99 | 9.3 | 7.18 | 6.42 | 6.16 | |
| Other Operating Activities | 1.09 | 0.5 | -3.34 | -3.7 | -1.39 | 0.98 | |
| Change in Accounts Receivable | 0.7 | -0.63 | -0.42 | -0.45 | 0.41 | -0.11 | |
| Change in Accounts Payable | -2.89 | -2.71 | -5.76 | 5.22 | 1.91 | 1.67 | |
| Change in Unearned Revenue | -10.91 | -1.36 | -10.66 | 22.46 | - | - | |
| Change in Other Net Operating Assets | 1.05 | 1.87 | -1.39 | 2.03 | -1.4 | -1.13 | |
| Operating Cash Flow | -45.27 | -64.85 | -85.94 | -35.36 | -67.53 | -51.44 | |
| Capital Expenditures | -0.09 | -0.18 | -1.01 | -0.51 | -0.81 | -0.23 | |
| Sale of Property, Plant & Equipment | 0.01 | - | 0.02 | - | - | - | |
| Investment in Securities | 30.43 | 23.13 | 51.76 | -74.43 | -11.87 | -14.68 | |
| Investing Cash Flow | 30.35 | 22.95 | 50.77 | -74.94 | -12.68 | -14.91 | |
| Issuance of Common Stock | 5.5 | 52 | 30.65 | 31.81 | 137.24 | 86.75 | |
| Financing Cash Flow | 5.5 | 52 | 30.65 | 31.81 | 137.24 | 86.75 | |
| Foreign Exchange Rate Adjustments | -0.02 | -0.05 | 0.03 | -0.02 | 0.01 | 0.06 | |
| Net Cash Flow | -9.44 | 10.05 | -4.49 | -78.51 | 57.03 | 20.45 | |
| Free Cash Flow | -45.36 | -65.03 | -86.94 | -35.87 | -68.34 | -51.67 | |
| Free Cash Flow Margin | -310.54% | -1053.83% | -479.27% | -91.92% | -621.96% | -747.32% | |
| Free Cash Flow Per Share | -0.24 | -0.35 | -0.52 | -0.24 | -0.64 | -0.68 | |
| Levered Free Cash Flow | -24.3 | -39.23 | -51.58 | -9.73 | -38.42 | -30.17 | |
| Unlevered Free Cash Flow | -24.23 | -39.15 | -51.3 | -8.65 | -36.63 | -27.66 | |
| Change in Working Capital | -12.05 | -2.83 | -18.23 | 29.24 | 0.93 | 0.43 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.